Biotech Distilled 133 companies · 839 active programs
Substack ↗ Subscribe

Home › Therapeutic areas › GI/Hepatology

GI/Hepatology (11 companies · 7 conditions)

Conditions

Alcohol-Associated Liver Disease 2 Celiac Disease 2 Eosinophilic Esophagitis 2 Rare Gastroparesis 2 Wilson's Disease 2 Rare Inflammatory Bowel Disease 1 Nausea and Vomiting 1

Companies

Ticker Company Therapeutic areas In GI/Hepatology Lead stage Programs
ABSI Absci Corporation DermatologyGI/HepatologyWomen's Health 1 Phase 1 7
ALT Altimmune, Inc. GI/HepatologyMetabolicNeurology 1 Phase 2 3
ANAB ANAPTYSBIO, INC DermatologyGI/HepatologyImmunologyOncology Rare 2 Approved 6
CLDX Celldex Therapeutics, Inc. DermatologyGI/HepatologyImmunologyRespiratory 0 Phase 3 7
DBVT DBV Technologies S.A. GI/HepatologyImmunology Rare 1 NDA Submitted 3
ETON Eton Pharmaceuticals, Inc. GI/HepatologyMetabolicRenal Rare 2 Approved 14
FBRX Forte Biosciences, Inc. DermatologyGI/Hepatology 1 Phase 2 3
PCSA Processa Pharmaceuticals, Inc. GI/HepatologyOncologyRenal Rare 1 Phase 2 8
RARE Ultragenyx Pharmaceutical Inc. CardiovascularGI/HepatologyMetabolicNeurology Rare 1 Approved 12
VNDA Vanda Pharmaceuticals Inc. CardiovascularDermatologyGI/HepatologyHematologyImmunologyInfectious DiseaseNeurologyOphthalmology Rare 2 Approved 26
VKTX Viking Therapeutics, Inc. GI/HepatologyMetabolicNeurology Rare 1 Phase 3 9